← Eichor
Study identifier: NCT06764706 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Severe Ulcerative Colitis

Condition: Ulcerative Colitis  ·  Sponsor: AbbVie

PhaseN/A
Planned participants200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine). This study will assess the change in disease activity of risankizumab treatment in adult participants with moderate to severe UC in real-world clinical practice. Risankizumab is an approved drug for treating participants with ulcerative colitis. Approximately 200 participants who are prescribed risankizumab by their physician in accordance with local label will be enrolled in approximately multiple sites across Germany and Austria. Participants will receive risankizumab as prescribed by their physician according to their routine clinical practice and local label. Participants will be followed for up to 52 weeks. There is expected to be no additional burden for participants in this trial. Participants will attend regular visits during the study at a hospital or clinic according to their routine clinical practice.

This description comes directly from the study's public registry record.

Talk to the study team

Medical Information Germany  ·  49 611 1720 1520  ·  medinfo.germany@abbvie.com

Always discuss trial participation with your own doctor first.

Locations (56)

Universitaetsklinikum Heidelberg /ID# 275906Heidelberg, Baden-Wurttemberg, GermanyRecruiting
Klinikum Ernst Von Bergmann /ID# 278268Potsdam, Brandenburg, GermanyRecruiting
Private Practice - Dr. Kempelmann /ID# 275726Tostedt, Free and Hanseatic City of Hamburg, GermanyRecruiting
Gastroenterologische Schwerpunktpraxis - Hannover /ID# 276701Hanover, Lower Saxony, GermanyRecruiting
Praxis fuer Gastroenterologie - Schwerin /ID# 275946Schwerin, Mecklenburg-Vorpommern, GermanyRecruiting
Medizinisches Versorgungszentrum Ahaus /ID# 280966Ahaus, North Rhine-Westphalia, GermanyRecruiting
Gastropraxis Bochum /ID# 281375Bochum, North Rhine-Westphalia, GermanyRecruiting
Katholisches Klinikum Bochum gGmbH /ID# 279486Bochum, North Rhine-Westphalia, GermanyRecruiting
Evangelisches Krankenhaus Kalk /ID# 276414Cologne, North Rhine-Westphalia, GermanyRecruiting
Dres. Kamp & Partner /ID# 275904Minden, North Rhine-Westphalia, GermanyRecruiting
Gemeinschaftspraxis Innere Medizin /ID# 280068Witten, North Rhine-Westphalia, GermanyRecruiting
Gastroenterologische Gemeinschaftspraxis Im Loehr-Center Koblenz /ID# 275943Koblenz, Rhineland-Palatinate, GermanyRecruiting

+ 44 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06764706